D. E. Shaw & Co., Inc. Incyte Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $3.32 Million - $4.04 Million	-40,000 Reduced 57.14%	30,000 $2.5 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $3.74 Million - $4.66 Million	40,000 Added 133.33%	70,000 $6.63 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.27 Million - $4.15 Million	30,000	30,000 $3.5 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.